NCT01839500 A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer Status COMPLETED Phase N/A
NCT01838109 Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery Status COMPLETED Phase NA
NCT01836991 D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01836120 A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01830907 Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002 Status COMPLETED Phase EARLY_PHASE1
NCT01824953 Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years Status COMPLETED Phase N/A
NCT01824459 S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients Status COMPLETED Phase PHASE3
NCT01815853 Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01813253 Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE3
NCT01803503 Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors Status UNKNOWN Phase PHASE2
NCT01798251 XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach Status UNKNOWN Phase PHASE2
NCT01795768 Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours Status UNKNOWN Phase PHASE2
NCT01795027 Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Status UNKNOWN Phase PHASE3
NCT01787539 The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT01783951 Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01779583 Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study") Status UNKNOWN Phase N/A
NCT01774786 A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer Status COMPLETED Phase PHASE3